Health
A Precision Strike Against Lung Cancer's Hidden Target
Zongertinib's Beamion LUNG-1 trial delivers breakthrough results for HER2-mutant NSCLC, including remarkable brain metastasis control
Tag
Zongertinib's Beamion LUNG-1 trial delivers breakthrough results for HER2-mutant NSCLC, including remarkable brain metastasis control